Turn Therapeutics Inc.
TTRX
$6.93
$0.111.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -971.00K | 279.10K | -1.90M | -- | -328.50K |
| Total Depreciation and Amortization | 14.50K | 14.20K | 13.70K | -- | 12.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.90K | -2.20M | 39.40K | -- | 326.00K |
| Change in Net Operating Assets | -737.20K | 732.60K | 1.26M | -- | -307.90K |
| Cash from Operations | -1.63M | -1.18M | -588.60K | -399.00K | -298.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.20K | -31.40K | -89.80K | -- | -- |
| Cash from Investing | -12.20K | -31.40K | -89.80K | -15.90K | -15.90K |
| Total Debt Issued | 6.72M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.07M | 3.18M | 594.60K | -- | 998.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.79M | 3.18M | 594.60K | 1.57M | 998.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.14M | 1.97M | -83.80K | 1.16M | 700.00K |